We manage the pricing and reimbursement of human medicinal products, from market entry through to the annual pricing periods, in a way that is compliant and commercially sound.
Pricing
- Preparation and follow-up of TİTCK price applications (initial price, price change, actual source price change period)
- Reference country price research; actual source price and benchmark source price calculations
- Applications for price-protected products, below-threshold products and cost-card pricing
- Analysis and reporting of the impact of the fixed euro rate and regulatory changes (Decree, Communiqué, Guideline) on the product portfolio
Reimbursement
- Preparation of SGK reimbursement application dossiers; follow-up of TEDK and Medicines Reimbursement Commission procedures
- Calculation of the impact of the SGK institutional discount and generic entries on price and discount
- Monitoring of SUT amendments and assessment of their impact on products
- Applications under the SGK Dynamic Procurement System (DAS) for medicines supplied from abroad
- Support for alternative reimbursement and pharmacoeconomic evaluation dossiers
Market Access Strategy
- Pricing and reimbursement scenarios and revenue projections ahead of product launch
